CalSTRS Likes Real Estate and PE, Cautious On Equities
Chris Ailman, Chief Investment Officer at CalSTRS Investments, on why he's neutrally positioned right now. Ellen Wald, President of Transversal Consulting, Senior Fellow at the Atlantic Council, and a...
1 Apr 201928min
Stocks More Attractive Than Alternatives: Bill Miller
Legendary investor Bill Miller, chairman and chief investment officer of Miller Value Partners, LLC, on value investing and his current investment outlook. Kate Moore, Managing Director, Chief Equity...
29 Mars 201934min
Aireon’s Space-Based System Tracks Planes In Real Time
Don Thoma, CEO of Mclean, VA-based Aireon, on its space-based surveillance system that will soon be tracking aircraft globally and in real-time for the first time ever. Melissa Reagen, Head of Resear...
28 Mars 201927min
Former CFTC Head Bowen on Advancing Women in Business
Sharon Bowen, Former US Commodity Futures Trading Commissioner and Seneca Women Partner, on advancing women in the economy and around the world. Carolyn Tastad, P&G North America Group President, on e...
27 Mars 201927min
LNG CEO: Asia, Europe Demand Propel U.S. Gas Projects
Greg Vesey, CEO & Managing Director of LNG Ltd., on the future of LNG and growing demand in Asia and Europe. John Lavelle, President & CEO, Offshore Wind, GE Renewable Energy, on the offshore wind bo...
26 Mars 201926min
How Corporate America Is Paying For EV Infrastructure (Podcast)
Broadcasting Live from Bloomberg's New Energy Finance Forum in NYC.Pasquale Romano, CEO of ChargePoint, one of the world’s largest charging station companies, on their recent capital raise, and laying...
25 Mars 201927min
AFL-CIO Won’t Support USMCA Without Mexico Wage Fix (Podcast)
Richard Trumka, President of the AFL-CIO, on why the union won’t support the new Nafta/USMCA trade agreement if an early vote is pursued. Matt Eagan, portfolio manager and co-head of Loomis Sayles’ F...
25 Mars 201927min
Biogen Was The Train Wreck Everyone Saw Coming: Nisen (Podcast)
Max Nisen, Bloomberg Opinion health care columnist, on Biogen plunging after the company and its partner Eisai announced it was halting their Alzheimer drug trial. Gad Levanon, Chief Economist: North ...
21 Mars 201926min
